LONSARIS

Class [005]
Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, namely psychiatric disorders, namely schizophrenia, bipolar disorder, depressive disorders, psychosis, irritability associated with autistic disorder, and reward disorders, namely eating disorders; Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of neurodegenerative diseases, namely Parkinson's disease and amyotrophic lateral sclerosis (ALS); Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of cardiovascular diseases; Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of metabolic diseases, namely diabetes, dyslipidemia and obesity.